Literature DB >> 21801345

Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis.

Steven E Kern1, Alfred B Tiono, Michael Makanga, Adama Dodji Gbadoé, Zulfiqarali Premji, Oumar Gaye, Issaka Sagara, David Ubben, Marc Cousin, Fiyinfolu Oladiran, Oliver Sander, Bernhards Ogutu.   

Abstract

BACKGROUND: Asymptomatic carriers of Plasmodium falciparum serve as a reservoir of parasites for malaria transmission. Identification and treatment of asymptomatic carriers within a region may reduce the parasite reservoir and influence malaria transmission in that area.
METHODS: Using computer simulation, this analysis explored the impact of community screening campaigns (CSC) followed by systematic treatment of P. falciparum asymptomatic carriers (AC) with artemether-lumefantrine (AL) on disease transmission. The model created by Okell et al (originally designed to explore the impact of the introduction of treatment with artemisinin-based combination therapy on malaria endemicity) was modified to represent CSC and treatment of AC with AL, with the addition of malaria vector seasonality. The age grouping, relative distribution of age in a region, and degree of heterogeneity in disease transmission were maintained. The number and frequency of CSC and their relative timing were explored in terms of their effect on malaria incidence. A sensitivity analysis was conducted to determine the factors with the greatest impact on the model predictions.
RESULTS: The simulation showed that the intervention that had the largest effect was performed in an area with high endemicity (entomological inoculation rate, EIR > 200); however, the rate of infection returned to its normal level in the subsequent year, unless the intervention was repeated. In areas with low disease burden (EIR < 10), the reduction was sustained for over three years after a single intervention. Three CSC scheduled in close succession (monthly intervals) at the start of the dry season had the greatest impact on the success of the intervention.
CONCLUSIONS: Community screening and treatment of asymptomatic carriers with AL may reduce malaria transmission significantly. The initial level of disease intensity has the greatest impact on the potential magnitude and duration of malaria reduction. When combined with other interventions (e.g. long-lasting insecticide-treated nets, rapid diagnostic tests, prompt diagnosis and treatment, and, where appropriate, indoor residual spraying) the effect of this intervention can be sustained for many years, and it could become a tool to accelerate the reduction in transmission intensity to pre-elimination levels. Repeated interventions at least every other year may help to prolong the effect. The use of an effective diagnostic tool and a highly effective ACT, such as AL, is also vital. The modelling supports the evaluation of this approach in a prospective clinical trial to reduce the pool of infective vectors for malaria transmission in an area with marked seasonality.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21801345      PMCID: PMC3161019          DOI: 10.1186/1475-2875-10-210

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


  22 in total

1.  A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.

Authors:  G Lefèvre; S Looareesuwan; S Treeprasertsuk; S Krudsood; U Silachamroon; I Gathmann; R Mull; R Bakshi
Journal:  Am J Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.345

2.  Anaemia caused by asymptomatic Plasmodium falciparum infection in semi-immune African schoolchildren.

Authors:  J A Kurtzhals; M M Addae; B D Akanmori; S Dunyo; K A Koram; M A Appawu; F K Nkrumah; L Hviid
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Nov-Dec       Impact factor: 2.184

Review 3.  The economic and social burden of malaria.

Authors:  Jeffrey Sachs; Pia Malaney
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

4.  High prevalence of asymptomatic plasmodium falciparum infections in a highland area of western Kenya: a cohort study.

Authors:  Frederick N Baliraine; Yaw A Afrane; Dolphine A Amenya; Mariangela Bonizzoni; David M Menge; Goufa Zhou; Daibin Zhong; Anne M Vardo-Zalik; Andrew K Githeko; Guiyun Yan
Journal:  J Infect Dis       Date:  2009-07-01       Impact factor: 5.226

5.  The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia.

Authors:  Lorenz von Seidlein; Gijs Walraven; Paul J Milligan; Neal Alexander; Fandingding Manneh; Jacqueline L Deen; Roz Coleman; Musa Jawara; Steve W Lindsay; Chris Drakeley; Sarah De Martin; Piero Olliaro; Steve Bennett; Maarten Schim van der Loeff; Kunle Okunoye; Geoff A Targett; Keith P McAdam; Justin F Doherty; Brian M Greenwood; Margaret Pinder
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Mar-Apr       Impact factor: 2.184

6.  Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum.

Authors:  Samuel Dunyo; Paul Milligan; Tansy Edwards; Colin Sutherland; Geoffrey Targett; Margaret Pinder
Journal:  PLoS Clin Trials       Date:  2006-08-18

7.  Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether.

Authors:  Colin J Sutherland; Rosalynn Ord; Sam Dunyo; Musa Jawara; Christopher J Drakeley; Neal Alexander; Rosalind Coleman; Margaret Pinder; Gijs Walraven; Geoffrey A T Targett
Journal:  PLoS Med       Date:  2005-04-26       Impact factor: 11.069

8.  Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment.

Authors:  Mac Otten; Maru Aregawi; Wilson Were; Corine Karema; Ambachew Medin; Worku Bekele; Daddi Jima; Khoti Gausi; Ryuichi Komatsu; Eline Korenromp; Daniel Low-Beer; Mark Grabowsky
Journal:  Malar J       Date:  2009-01-14       Impact factor: 2.979

Review 9.  The role of anti-malarial drugs in eliminating malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

10.  Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar.

Authors:  Achuyt Bhattarai; Abdullah S Ali; S Patrick Kachur; Andreas Mårtensson; Ali K Abbas; Rashid Khatib; Abdul-Wahiyd Al-Mafazy; Mahdi Ramsan; Guida Rotllant; Jan F Gerstenmaier; Fabrizio Molteni; Salim Abdulla; Scott M Montgomery; Akira Kaneko; Anders Björkman
Journal:  PLoS Med       Date:  2007-11-06       Impact factor: 11.069

View more
  39 in total

1.  Seasonal Variation in the Epidemiology of Asymptomatic Plasmodium falciparum Infections across Two Catchment Areas in Bongo District, Ghana.

Authors:  Kathryn E Tiedje; Abraham R Oduro; Godfred Agongo; Thomas Anyorigiya; Daniel Azongo; Timothy Awine; Anita Ghansah; Mercedes Pascual; Kwadwo A Koram; Karen P Day
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

2.  Community-wide Prevalence of Malaria Parasitemia in HIV-Infected and Uninfected Populations in a High-Transmission Setting in Uganda.

Authors:  Shereen Katrak; Nathan Day; Emmanuel Ssemmondo; Dalsone Kwarisiima; Alemayehu Midekisa; Bryan Greenhouse; Moses Kamya; Diane Havlir; Grant Dorsey
Journal:  J Infect Dis       Date:  2016-02-10       Impact factor: 5.226

3.  A periodic disease transmission model with asymptomatic carriage and latency periods.

Authors:  Isam Al-Darabsah; Yuan Yuan
Journal:  J Math Biol       Date:  2017-12-22       Impact factor: 2.259

4.  Treatment of Chronic Asymptomatic Plasmodium falciparum Infection Does Not Increase the Risk of Clinical Malaria Upon Reinfection.

Authors:  Silvia Portugal; Tuan M Tran; Aissata Ongoiba; Aboudramane Bathily; Shanping Li; Safiatou Doumbo; Jeff Skinner; Didier Doumtabe; Younoussou Kone; Jules Sangala; Aarti Jain; D Huw Davies; Christopher Hung; Li Liang; Stacy Ricklefs; Manijeh Vafa Homann; Philip L Felgner; Stephen F Porcella; Anna Färnert; Ogobara K Doumbo; Kassoum Kayentao; Brian M Greenwood; Boubacar Traore; Peter D Crompton
Journal:  Clin Infect Dis       Date:  2017-03-01       Impact factor: 9.079

5.  Differential impact of sickle cell trait on symptomatic and asymptomatic malaria.

Authors:  Eunha Shim; Zhilan Feng; Carlos Castillo-Chavez
Journal:  Math Biosci Eng       Date:  2012-10       Impact factor: 2.080

6.  Modeling the human infectious reservoir for malaria control: does heterogeneity matter?

Authors:  Elsa Hansen; Caroline O Buckee
Journal:  Trends Parasitol       Date:  2013-04-15

7.  Genetic Evidence of Focal Plasmodium falciparum Transmission in a Pre-elimination Setting in Southern Province, Zambia.

Authors:  Julia C Pringle; Sofonias Tessema; Amy Wesolowski; Anna Chen; Maxwell Murphy; Giovanna Carpi; Timothy M Shields; Harry Hamapumbu; Kelly M Searle; Tamaki Kobayashi; Ben Katowa; Michael Musonda; Jennifer C Stevenson; Philip E Thuma; Bryan Greenhouse; William J Moss; Douglas E Norris
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

8.  Prevalence of the Pfdhfr and Pfdhps mutations among asymptomatic pregnant women in Southeast Nigeria.

Authors:  Ekpereonne Esu; Costanza Tacoli; Prabhanjan Gai; Nicole Berens-Riha; Michael Pritsch; Thomas Loescher; Martin Meremikwu
Journal:  Parasitol Res       Date:  2018-01-13       Impact factor: 2.289

Review 9.  Designing the next generation of medicines for malaria control and eradication.

Authors:  Jeremy N Burrows; Rob Hooft van Huijsduijnen; Jörg J Möhrle; Claude Oeuvray; Timothy N C Wells
Journal:  Malar J       Date:  2013-06-06       Impact factor: 2.979

10.  Modelling the cost-effectiveness of mass screening and treatment for reducing Plasmodium falciparum malaria burden.

Authors:  Valerie Crowell; Olivier J T Briët; Diggory Hardy; Nakul Chitnis; Nicolas Maire; Aurelio Di Pasquale; Thomas A Smith
Journal:  Malar J       Date:  2013-01-03       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.